Revised SPC: Keytruda (pembrolizumab) 25 mg/mL concentrate for solution for infusion
The indication for classical Hodgkin lymphoma has been extended to include paediatric patients aged 3 years and older.
Source:
electronic Medicines compendium
The indication for classical Hodgkin lymphoma has been extended to include paediatric patients aged 3 years and older.
electronic Medicines compendium